TANDEM DIABETES CARE, INC. Tandem Diabetes Care, Inc. Stock
Equities
TNDM
US8753722037
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.46 USD | +0.79% |
|
-3.20% | +33.00% |
| Jul. 01 | Tandem Diabetes Care, Inc.(NasdaqGM:TNDM) dropped from Russell 1000 Growth Index | CI |
| Jul. 01 | Tandem Diabetes Care, Inc.(NasdaqGM:TNDM) dropped from Russell 1000 Value Index | CI |
Financials (USD)
| Sales 2024 * | 869M | Sales 2025 * | 961M | Capitalization | 2.53B |
|---|---|---|---|---|---|
| Net income 2024 * | -110M | Net income 2025 * | -74M | EV / Sales 2024 * | 2.81 x |
| Net cash position 2024 * | 88.94M | Net cash position 2025 * | 48.12M | EV / Sales 2025 * | 2.58 x |
| P/E ratio 2024 * |
-23.6
x | P/E ratio 2025 * |
-35.2
x | Employees | 2,400 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.24% |
More Fundamentals
* Assessed data
More news
Latest transcript on Tandem Diabetes Care, Inc.
More recommendations
More press releases
| 1 day | +0.79% | ||
| 1 week | -3.20% | ||
| Current month | -2.36% | ||
| 1 month | -24.32% | ||
| 3 months | +14.83% | ||
| 6 months | +44.58% | ||
| Current year | +33.00% |
1 week
38.58
42.29
1 month
38.5853.64
Current year
21.8553.69
1 year
13.8253.69
3 years
13.82155.86
5 years
13.82155.86
10 years
2.14179.80
| Managers | Title | Age | Since |
|---|---|---|---|
John Sheridan
CEO | Chief Executive Officer | 68 | 13-02-28 |
Leigh Vosseller
DFI | Director of Finance/CFO | 51 | 13-08-31 |
Shannon Hansen
CMP | Compliance Officer | 58 | 21-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 63 | 19-01-02 | |
| Director/Board Member | 64 | 13-06-30 | |
John Sheridan
CEO | Chief Executive Officer | 68 | 13-02-28 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.45% | 2 M€ | +6.93% | ||
| 0.32% | 415 M€ | -.--% | ||
| 0.10% | 12 M€ | -.--% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-07-03 | 39.37 | +0.56% | 342 477 |
| 24-07-02 | 39.15 | -0.76% | 1,285,526 |
| 24-07-01 | 39.45 | -2.08% | 1,500,848 |
| 24-06-28 | 40.29 | -0.35% | 9,715,617 |
| 24-06-27 | 40.43 | -0.52% | 1,554,436 |
Delayed Quote Nasdaq, July 03, 2024 at 12:02 pm EDT
More quotes
Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
Calendar
2024-07-31
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
39.15
USD
Average target price
49.93
USD
Spread / Average Target
+27.54%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +33.00% | 2.53B | |
| -7.04% | 180B | |
| -6.13% | 99.21B | |
| -6.27% | 66.25B | |
| -10.75% | 44.74B | |
| +7.70% | 43.82B | |
| +10.35% | 41.96B | |
| +11.16% | 28.98B | |
| +16.18% | 24.07B | |
| -8.82% | 23.5B |
- Stock Market
- Equities
- TNDM Stock
